CAS:232280-88-5

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:2965-17-5

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:439692-05-4

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:227279-10-9

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:98021-79-5

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:754190-97-1

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:1330767-26-4

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:363179-59-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:1505987-37-0

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:659724-77-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:536-43-6

Active Ingredients:Dyclocaine HCl

Chemical Formula:C₁₈H₂₇NO₂·HCl

Molecular Weight:325.88

Assay:≥ 98.0%(Calculated as anhydrous and solvent-free)

Pharmacopeia:CP

Package Type:Aluminum foil

Shelf Life:18 months

Storage:Sealed

Place of Origin:China

CAS:906673-24-3

Active Ingredients:Crisaborole

Chemical Formula:C₁₄H₁₀BNO₃

Molecular Weight:251.04

Assay:≥ 98.0%(Calculated as anhydrous and solvent-free)

Pharmacopeia:CP

Package Type:Aluminum foil

Shelf Life:18 months

Storage:Sealed

Place of Origin:China

CAS:350996-91-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:59107-99-2

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:51012-63-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:6938-26-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:87172-81-4

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

Indication:For the treatment of essential hypertension. For the treatment of patients whose blood pressure cannot be effectively controlled by using irbesartan or hydrochlorothiazide alone.

Specification:150 mg of irbesartan and 12.5 mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For the treatment of essential hypertension

Specification:Each tablet contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine besylate

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of hypertension. Indicated in patients whose blood pressure is not adequately controlled with olmesartan medoxomil or hydrochlorothiazide alone.

Specification:Per Tablet Contains: Olmesartan medoxomil 20 mg and Hydrochlorothiazide 12.5 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP